![](https://www.acepnow.com/wp-content/uploads/2023/12/practice-changers-dec-2023.jpg)
References
- Thiessen ME, Godwin SA, Hatten BW, et al. Clinical policy: Critical issues in the evaluation and management of adult out-of-hospital or emergency department patients presenting with severe agitation. ACEP website. Published October 6, 2023. Accessed November 30, 2023.
- ACEP Policy statement: Use of droperidol in the emergency department. ACEP website. Published January, 2021. Accessed November 30, 2023.
- Taylor DM, Yap CYL, Knott JC, et al. Midazolam-droperidol, droperidol, or olanzapine for acute agitation: a randomized clinical trial. Ann Emerg Med. 2017;69(3).
- Klein LR, Driver BE, Miner JR, et al. Intramuscular midazolam, olanzapine, ziprasidone, or haloperidol for treating acute agitation in the emergency department. Ann Emerg Med. 2018;72(4).
- Barbic D, Andolfatto G, Grunau B, et al. Rapid agitation control with ketamine in the emergency department: a blinded, randomized controlled trial. Ann Emerg Med. 2021;78(6):788-795.
Explore This Issue
ACEP Now: Vol 42 – No 12 – December 2023Pages: 1 2 3 | Single Page
No Responses to “Which Sedatives Are Best for Managing Severe Agitation in the Emergency Department?”